Global Conferences RLT Education RLT Components Sponsors Trial Stats 
How to NavigateNEW Ecosystem Connect Distinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats Dictionary About Us Our Values
Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comThe global state of
theranostic clinical
trials.
Active and archived clinical trials across radiopharmaceutical therapy and imaging — compiled in real time from the TheranosticTrials.org registry.
Lead radioisotopes powering the field.
Ranked by the number of active clinical trials utilizing each radioisotope. Therapeutic emitters (alpha, beta) are reported separately from imaging emitters (gamma, positron), with a combined view showing the full field by primary emission type.
Cancer types by trial volume.
The ten indications drawing the largest concentration of theranostic research today. Prostate, neuroendocrine, and selected solid tumors dominate the landscape as isotope-targeted therapies mature.
A network spanning continents.
TheranosticTrials.org is accessed by clinicians, researchers, industry partners, and patients across every inhabited continent — a snapshot of the global community driving radiopharmaceutical science forward.
Share your feedback
Help us improve your experience